QDEL
Income statement / Annual
Last year (2025), QuidelOrtho Corporation's total revenue was $2.73 B,
a decrease of 1.89% from the previous year.
In 2025, QuidelOrtho Corporation's net income was -$1.13 B.
See QuidelOrtho Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/28/2025 |
12/29/2024 |
12/31/2023 |
01/01/2023 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$2.73 B |
$2.78 B |
$3.00 B |
$3.27 B |
$1.70 B |
$1.66 B |
$534.89 M |
$522.29 M |
$277.74 M |
$191.60 M |
| Cost of Revenue |
$1.46 B
|
$1.50 B
|
$1.50 B
|
$1.33 B
|
$420.30 M
|
$312.81 M
|
$214.09 M
|
$206.57 M
|
$121.60 M
|
$73.41 M
|
| Gross Profit |
$1.27 B
|
$1.29 B
|
$1.50 B
|
$1.94 B
|
$1.28 B
|
$1.35 B
|
$320.81 M
|
$315.71 M
|
$156.14 M
|
$118.19 M
|
| Gross Profit Ratio |
0.47
|
0.46
|
0.5
|
0.59
|
0.75
|
0.81
|
0.6
|
0.6
|
0.56
|
0.62
|
| Research and Development Expenses |
$186.20 M
|
$218.70 M
|
$246.80 M
|
$187.90 M
|
$95.70 M
|
$84.29 M
|
$52.55 M
|
$51.65 M
|
$33.64 M
|
$38.67 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$225.90 M
|
$66.59 M
|
$52.76 M
|
$44.95 M
|
$29.19 M
|
$27.06 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$13.70 M
|
$133.96 M
|
$111.11 M
|
$108.99 M
|
$67.25 M
|
$47.82 M
|
| Selling, General & Administrative Expenses |
$746.30 M
|
$766.80 M
|
$763.20 M
|
$621.00 M
|
$239.60 M
|
$200.54 M
|
$163.87 M
|
$153.94 M
|
$96.44 M
|
$74.88 M
|
| Other Expenses |
$1.26 B
|
$2.26 B
|
$349.80 M
|
$283.60 M
|
$37.00 M
|
$3.69 M
|
$11.67 M
|
$0.00
|
$0.00
|
$9.07 M
|
| Operating Expenses |
$2.19 B
|
$3.25 B
|
$1.36 B
|
$1.09 B
|
$372.30 M
|
$288.53 M
|
$228.09 M
|
$205.59 M
|
$130.08 M
|
$122.63 M
|
| Cost And Expenses |
$3.65 B
|
$4.74 B
|
$2.86 B
|
$2.42 B
|
$792.60 M
|
$601.34 M
|
$442.17 M
|
$412.16 M
|
$251.69 M
|
$196.04 M
|
| Interest Income |
$0.00
|
$0.00
|
$2.20 M
|
$1.30 M
|
$300.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$177.60 M
|
$188.30 M
|
$178.90 M
|
$74.50 M
|
$700.00 K
|
$1.26 M
|
$14.79 M
|
$24.28 M
|
$17.59 M
|
$12.18 M
|
| Depreciation & Amortization |
$442.00 M
|
$453.40 M
|
$457.20 M
|
$283.60 M
|
$52.70 M
|
$49.09 M
|
$47.83 M
|
$46.27 M
|
$30.76 M
|
$31.87 M
|
| EBITDA |
-$488.10 M |
-$1.49 B |
$607.00 M |
$1.09 B |
$953.30 M |
$1.10 B |
$139.80 M |
$133.93 M |
$40.31 M |
$18.78 M |
| EBITDA Ratio |
-0.18
|
-0.54
|
0.2
|
0.33
|
0.56
|
0.66
|
0.26
|
0.26
|
0.15
|
0.1
|
| Operating Income Ratio |
-0.34
|
-0.7
|
0.05
|
0.26
|
0.53
|
0.64
|
0.17
|
0.18
|
0.03
|
-0.02
|
| Total Other Income/Expenses Net |
-$188.50 M
|
-$170.60 M
|
-$168.20 M
|
-$107.80 M
|
-$5.70 M
|
-$20.01 M
|
-$15.54 M
|
-$32.55 M
|
-$17.59 M
|
-$11.76 M
|
| Income Before Tax |
-$1.11 B
|
-$2.13 B
|
-$29.10 M
|
$735.90 M
|
$900.30 M
|
$1.04 B
|
$77.18 M
|
$63.38 M
|
-$8.04 M
|
-$16.20 M
|
| Income Before Tax Ratio |
-0.41
|
-0.77
|
-0.01
|
0.23
|
0.53
|
0.63
|
0.14
|
0.12
|
-0.03
|
-0.08
|
| Income Tax Expense |
$24.10 M
|
-$79.50 M
|
-$19.00 M
|
$187.20 M
|
$196.10 M
|
$230.03 M
|
$4.26 M
|
-$10.80 M
|
$129.00 K
|
-$2.39 M
|
| Net Income |
-$1.13 B
|
-$2.05 B
|
-$10.10 M
|
$548.70 M
|
$704.20 M
|
$810.29 M
|
$72.92 M
|
$74.18 M
|
-$8.17 M
|
-$13.81 M
|
| Net Income Ratio |
-0.41
|
-0.74
|
-0
|
0.17
|
0.41
|
0.49
|
0.14
|
0.14
|
-0.03
|
-0.07
|
| EPS |
-16.69 |
-30.54 |
-0.15 |
9.66 |
16.74 |
19.24 |
1.78 |
1.74 |
-0.24 |
-0.42 |
| EPS Diluted |
-16.69 |
-30.54 |
-0.15 |
9.56 |
16.43 |
18.6 |
1.73 |
1.74 |
-0.24 |
-0.42 |
| Weighted Average Shares Out |
$67.80 M
|
$67.20 M
|
$66.80 M
|
$56.80 M
|
$42.08 M
|
$42.12 M
|
$40.86 M
|
$42.55 M
|
$33.73 M
|
$32.71 M
|
| Weighted Average Shares Out Diluted |
$67.80 M
|
$67.20 M
|
$66.80 M
|
$57.40 M
|
$42.87 M
|
$43.59 M
|
$43.11 M
|
$42.55 M
|
$33.73 M
|
$32.71 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
